Menu
Not yet recruiting NCT07474805

Outcomes of Renal Replacement in Mexico

Observational Chronic Kidney Disease - Stage V Chronic Kidney Disease on Hemodialysis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Chronic Kidney Disease - Stage V, Chronic Kidney Disease on Hemodialysis. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Clinical Outcomes Study of Mexican Patients With Chronic Kidney Disease on Renal Replacement Therapy

Overview

A descriptive, observational, prospective, multicenter study aimed at describing the main clinical outcomes of patients with chronic kidney disease receiving any form of renal replacement therapy in Mexico.

Primary outcome measures

  • All-cause mortality [Time frame: From enrollment in the study until death from any cause or end of follow-up, assessed up to 3 years.]
Secondary outcome measures (2)
  • Hospitalizations per patient-year [Time frame: From enrollment until the end of follow-up, assessed up to 3 years]
  • Infection rate [Time frame: From enrollment until the end of follow-up, assessed up to 3 years]

Eligibility criteria

Inclusion criteria

  • Willingness to participate and provision of written informed consent
  • Diagnosis of chronic kidney disease and treatment with hemodialysis or peritoneal dialysis for ≥3 months
  • Availability of a medical record containing information on the study variables
  • Receiving care at one of the participating centers

Exclusion criteria

  • Life expectancy <3 months due to a cause unrelated to chronic kidney disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07474805 · NMM-5533-25-28-1

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗